If I knew about R327 and had a bad UTI, I'd be phoning Graham and insisting on giving me some right a way.
Hope capital raise is only to get us past an actual trial on actual UTI sufferers, cause theoretically it should smash UTI for six, then share price can surge and then we get funding for future accelerated action.
If I was working at RCE's lab, it would be awfully tempting to peddle bootleg R327. Shame the medical world works at glacial pace. Those of us who do low carb intermittent fasting (a la late Dr Mosely style or more so) whose lives are transformed for only the better will be waiting another 10 years or more before it becomes official mainstream acceptance. This all helps explain me why this R327 is taking so long.
RCE Price at posting:
60.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)